American College Of Cardiology 2004 Scientific Sessions In Brief
This article was originally published in The Gray Sheet
Executive Summary
Expanded Cypher use: Sirolimus-eluting stents are effective in treating lesions in relatively narrow vessels, according to eight-month data from the 257-patient SES-SMART trial comparing Johnson & Johnson/Cordis' Cypherwith the firm's bare-metal Bx Velocity. Binary restenosis was 9.8% and 53.1% for the Cypher and control groups, respectively; major cardiac event rates were 9.3% for Cypher and 31.3% for control. Mean vessel diameter was 2.2 mm; mean pre-procedure lumen diameter was 0.72 mm. Cypher currently is approved for vessels 2.5-3.5 mm in diameter...
You may also be interested in...
Tunis Praises NEJM Editorial Calling On Doctors To Care About Societal Costs
Physicians should take more responsibility for demonstrating cost-effectiveness of expensive therapies such as implantable cardioverter defibrillators, according to an editorial in the Dec. 9 issue of the New England Journal of Medicine
Tunis Praises NEJM Editorial Calling On Doctors To Care About Societal Costs
Physicians should take more responsibility for demonstrating cost-effectiveness of expensive therapies such as implantable cardioverter defibrillators, according to an editorial in the Dec. 9 issue of the New England Journal of Medicine
St. Jude To Announce RHYTHM Data As ACC Crowd Buzzes About SCD-HeFT
St. Jude Medical will present results from three pivotal cardiac rhythm management trials during the Annual Scientific Sessions of the American College of Cardiology in New Orleans, March 6-10